Acta Scientific Biotechnology (ASBT)

Editorial Volume 1 Issue 4

Challenges in the Management of Resistant Hypertension; Major Risk Factor for CVD

Verma MK*

Department of Biotechnology, Acharya Nagarjuna University, Nagarjuna Nagar, Guntur, Andhra Pradesh, India

*Corresponding Author: Verma MK, Department of Biotechnology, Acharya Nagarjuna University, Nagarjuna Nagar, Guntur, Andhra Pradesh, India. E-mail: mahendraverma1980@gmail.com

Received: February 28, 2020; Published: March 01, 2020

×

 Cardiovascular diseases (CVD) are the leading cause of death and physical impairment across the globe, affecting millions of lives annually. In general, CVD referred to as a set of diseases including arrhythmia, angina, stroke, embolism, and ischemia that occur in the vascular system, including cardiac and cerebral. As per recent reports from the World Health Organization (WHO) more than 30% of global deaths caused by cardiovascular diseases alone. The onset of CVD is multifactorial and challenging to diagnose precise risk factors. However, significant risk factors associated with CVD are obesity, unhealthy diet, hypertension, diabetes, and consumption of tobacco and alcohol.

×

References

  1. Deaton C., et al. “The global burden of cardiovascular disease”. European Journal of Cardiovascular Nursing 2 (2011): S5-13.
  2. Mensah GA., et al. “The Global Burden of Cardiovascular Diseases and Risk Factors 2020 and Beyond”. Journal of the American College of Cardiology 74.20 (2019).
  3. Benjamin EJ., et al. “Heart Disease and Stroke Statistics-2017 Update: A Report from the American Heart Association”. Circulation 135.10 (2017): e146-e603.
  4. Sanderson JE., et al. “Global burden of cardiovascular disease”. Heart 93.10 (2007): 1175.
  5. Kannel WB. “Blood pressure as a cardiovascular risk factor: prevention and treatment”. JAMA 275.20 (1996): 1571-1576.
  6. James PA., et al. “2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)”. JAMA 311.5 (2014): 507-520. 
  7. Renna NF. “Resistant hypertension: An update”. Hipertensión y Riesgo Vascular 36.1 (2019): 44-52. 
  8. Makris A., et al. “Resistant hypertension workup and approach to treatment”. International Journal of Hypertension 2011 (2010): 598694.
  9. Yaxley JP and Thambar SV. “Resistant hypertension: an approach to management in primary care”. Journal of Family Medicine and Primary Care 4 (2015): 193.
  10. Gu J., et al. “Association between long-term prescription of aldosterone antagonist and the progression of heart failure with preserved ejection fraction in hypertensive patients”. International Journal of Cardiology 220 (2016): 56-60.
×

Citation

Citation: Verma MK. “Challenges in the Management of Resistant Hypertension; Major Risk Factor for CVD".Acta Scientific Biotechnology 1.4 (2020): 01-02.




Member In



News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 15, 2020.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US